Fraser Brims
Cited by
Cited by
A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis
FJH Brims, TM Meniawy, I Duffus, D de Fonseka, A Segal, J Creaney, ...
Journal of Thoracic Oncology 11 (4), 573-582, 2016
Ambulatory treatment in the management of pneumothorax: a systematic review of the literature
FJH Brims, NA Maskell
Thorax 68 (7), 664-669, 2013
Empyema thoracis: new insights into an old disease
FJH Brims, SM Lansley, GW Waterer, YCG Lee
European Respiratory Review 19 (117), 220-228, 2010
Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients
RS Finn, FJH Brims, A Gandhi, N Olsen, AW Musk, NA Maskell, YCG Lee
Chest 142 (5), 1267-1273, 2012
Advance care planning uptake among patients with severe lung disease: a randomised patient preference trial of a nurse-led, facilitated advance care planning intervention
C Sinclair, KA Auret, SF Evans, F Williamson, S Dormer, A Wilkinson, ...
BMJ open 7 (2), e013415, 2017
Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids
FJH Brims, AJ Chauhan, B Higgins, JK Shute
Thorax 64 (12), 1037-1043, 2009
Coal workers’ pneumoconiosis: an Australian perspective
GR Zosky, RF Hoy, EJ Silverstone, FJ Brims, S Miles, AR Johnson, ...
The Medical Journal of Australia 204 (11), 414-418, 2016
Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool
M Weber, S Yap, D Goldsbury, D Manners, M Tammemagi, H Marshall, ...
International journal of cancer 141 (2), 242-253, 2017
Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
J Creaney, NJ Olsen, F Brims, IM Dick, AW Musk, NH de Klerk, SJ Skates, ...
Cancer epidemiology, biomarkers & prevention 19 (9), 2238-2246, 2010
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study
MC Tammemägi, M Ruparel, A Tremblay, R Myers, J Mayo, J Yee, ...
The Lancet Oncology 23 (1), 138-148, 2022
Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD
AC Asiimwe, FJH Brims, NP Andrews, DR Prytherch, BR Higgins, ...
Lung 189, 225-232, 2011
Protocol and rationale for the international lung screening trial
KP Lim, H Marshall, M Tammemägi, F Brims, A McWilliams, E Stone, ...
Annals of the American Thoracic Society 17 (4), 503-512, 2020
Outcomes and complications following medical thoracoscopy
FJH Brims, M Arif, AJ Chauhan
The clinical respiratory journal 6 (3), 144-149, 2012
Respiratory chest pain: diagnosis and treatment
FJH Brims, HE Davies, YCG Lee
Medical Clinics 94 (2), 217-232, 2010
Asbestos–a legacy and a persistent problem
FJH Brims
Journal of the Royal Naval Medical Service 95 (1), 2009
Air quality, tobacco smoke, urban crowding and day care: modern menaces and their effects on health
F Brims, AJ Chauhan
The Pediatric infectious disease journal 24 (11), S152-S158, 2005
Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
S Sneddon, JS Leon, IM Dick, G Cadby, N Olsen, F Brims, RJN Allcock, ...
Gene 563 (1), 103-105, 2015
Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial
F Brims, S Gunatilake, I Lawrie, L Marshall, C Fogg, C Qi, L Creech, ...
Thorax 74 (4), 354-361, 2019
Occupational lung diseases in Australia
RF Hoy, F Brims
Medical Journal of Australia 207 (10), 443-448, 2017
Bacteriology and clinical outcomes of patients with culture‐positive pleural infection in Western Australia: a 6‐year analysis
F Brims, N Popowicz, A Rosenstengel, J Hart, A Yogendran, CA Read, ...
Respirology 24 (2), 171-178, 2019
The system can't perform the operation now. Try again later.
Articles 1–20